Manager, Clinical Scientist, Internal Medicine
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Manager, Clinical Sciences (Internal Medicine) to join our Clinical Sciences team, supporting our cardiovascular, renal, and metabolic disease programs. In this role, you will help design, execute, and interpret clinical studies that advance our development pipeline while collaborating with Medical Directors and cross-functional teams.
Job description
Discover your role
- Support the planning, execution, and evaluation of early- and late-phase clinical studies
- Partner with Medical Directors to deliver scientific expertise for study and program design
- Contribute to program team meetings, advisory boards, steering committees, and safety monitoring meetings
- Develop a deep understanding of the disease area, drug mechanism, and competitive landscape
- Author and review key study documents, including protocol sections, monitoring plans, SAPs, informed consents, and Clinical Study Report components
- Review clinical and safety data to protect patient safety and ensure data integrity
- Identify study risks and propose practical mitigations
- Work with internal teams and external vendors to uphold study quality and compliance with FDA, EMA, ICH, and GCP standards
Requirements
- MS, PhD, or PharmD in a related field
- 5+ years of pharmaceutical clinical drug development experience
- Working knowledge of the drug development process, GCP, study design, and clinical research methodology
- Strong analytical, communication, and presentation skills, with the ability to influence within and across teams
- Demonstrated ability to solve complex problems independently and work effectively in a matrix environment
- Preferred: experience in cardiovascular, renal, or metabolic disease
- Preferred: medical writing skills and a track record of clinical trial process improvements
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.